Cue Biopharma, Inc.
Boston, United States
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Cue Biopharma, Inc was founded by Rodolfo Chaparro, Gary Schuman, Christopher Marlett, Steven Almo, Ronald Seidel III, Cameron Gray, Anthony DiGiandomenico, Amy Wang, STEVEN MCKNIGHT, DANIEL PASSERI, Barry Simon, Tamar G. Howson, Daniel R. Passeri, Aaron G. Fletcher, Peter A. Kiener, Kerri-Ann R. Millar, Anish R. Suri, Frank G. Morich, Frederick G. Driscoll, Patricia R. Nasshorn, Colin G. Sandercock, Ken R. Pienta, PETER KIENER, Patrick Verheyen, Daniel Baker, Frank Morich, Pamela D. Garzone, Colin Sandercock, Jill M. Broadfoot, Shao-Lee Lin and Pasha Sarraf, and is based in Boston, United States.
Key facts
- Industry
- Biotechnology
- Legal form
- Incorporated in Delaware
- Listed
- Nasdaq · CUE
About
Pharmaceutical Preparations; formerly Imagen Biopharma, Inc.; listed on Nasdaq as CUE; filing with the SEC since 2015
Founders
Vice President, Head of Immunology
1500 Founder Rating
Chief Financial Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Vice President, Head of Research and Development
1500 Founder Rating
Chief Executive Officer and President
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director
1500 Founder Rating
Director
1500 Founder Rating
Chief Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director
1500 Founder Rating
Director
1500 Founder Rating
In context
We hold 2,331 other biotechnology companies. None has a closure on record yet. Of the 2,210 that report what they raised, the median is $3,512,633.
Counted across this directory, from founding and closing years in public records. Medians cover only companies whose closure is recorded; a company with no closure date may have quietly ceased without the record catching it.
Discussion
Log in to join the discussion and like comments.
Log In to Comment